Facebook tracking pixel
O99.820
ICD-10-CM
Group B Streptococcus Positive in Pregnancy

Understanding Group B Strep Positive in Pregnancy: This resource provides essential information on GBS positive diagnosis, clinical documentation requirements, ICD-10 code O98.71, medical coding guidelines, and healthcare management during pregnancy. Learn about GBS screening, treatment options, risk factors, and prevention of neonatal GBS infection. Find reliable resources for accurate documentation and appropriate coding for GBS positive pregnant patients.

Also known as

GBS Positive in Pregnancy
Streptococcus B Carrier in Pregnancy

Diagnosis Snapshot

Key Facts
  • Definition : Bacterial infection with Group B Strep during pregnancy, usually harmless to mother but potentially serious for the newborn.
  • Clinical Signs : Often asymptomatic in mothers. Neonatal early-onset GBS can present with sepsis, pneumonia, meningitis.
  • Common Settings : Prenatal checkups, labor and delivery units, neonatal intensive care.

Related ICD-10 Code Ranges

Complete code families applicable to AAPC O99.820 Coding
O98.3-

Infectious diseases complicating pregnancy

Other specified infectious and parasitic diseases in pregnancy

B95-

Streptococcus and Staphylococcus as the cause of diseases classified elsewhere

Streptococcal and staphylococcal infections as the cause of diseases classified elsewhere

Z34-

Encounter for supervision of normal pregnancy

Encounters for supervision of normal pregnancy and delivery

Code-Specific Guidance

Decision Tree for

Follow this step-by-step guide to choose the correct ICD-10 code.

Is GBS colonization confirmed?

Code Comparison

Related Codes Comparison

When to use each related code

Description
GBS Positive, Pregnancy
GBS Bacteriuria, Pregnancy
GBS Sepsis, Neonatal

Documentation Best Practices

Documentation Checklist
  • GBS positive screening result details (e.g., week of gestation, culture method)
  • Treatment plan: intrapartum antibiotics documented (e.g., penicillin, ampicillin)
  • Maternal allergy information if applicable, alternative antibiotic selection noted
  • Intrapartum antibiotic administration times and dosage documented
  • Neonatal observation and management plan for possible GBS infection

Mitigation Tips

Best Practices
  • Intrapartum antibiotic prophylaxis (IAP) for GBS+ mothers.
  • Accurate GBS testing at 35-37 weeks gestation. Document in medical record.
  • Timely IAP administration: Penicillin G preferred, alternatives if allergic. Note reaction & alternative used.
  • Educate patient on GBS+ and IAP benefits. Document shared decision-making.
  • Monitor neonate for early-onset GBS disease. Thorough clinical documentation crucial.

Clinical Decision Support

Checklist
  • Verify GBS positive test result (ICD-10 O98.71)
  • Confirm gestational age documented for risk assessment
  • Check penicillin allergy status (RxNorm 706187)
  • Verify intrapartum antibiotic prophylaxis order
  • Document patient education on GBS+ in pregnancy

Reimbursement and Quality Metrics

Impact Summary
  • Diagnosis: Group B Strep Positive in Pregnancy Reimbursement and Quality Metrics Impact Summary
  • Keywords: GBS, Pregnancy, ICD-10 O98.71, Reimbursement, Medical Billing, Coding Accuracy, Hospital Reporting, Quality Metrics, Sepsis, Neonatal Infection
  • Impact 1: Accurate coding maximizes reimbursement for GBS screening and treatment.
  • Impact 2: Impacts quality metrics related to maternal and neonatal sepsis rates.
  • Impact 3: Proper documentation crucial for appropriate risk adjustment and resource allocation.
  • Impact 4: Affects hospital reporting on infection prevention and patient safety indicators.

Streamline Your Medical Coding

Let S10.AI help you select the most accurate ICD-10 codes. Our AI-powered assistant ensures compliance and reduces coding errors.

Frequently Asked Questions

Common Questions and Answers

Q: What is the optimal Group B Streptococcus (GBS) positive in pregnancy management protocol for reducing neonatal morbidity and mortality?

A: Managing GBS positive in pregnancy effectively is crucial for minimizing neonatal risks. The current gold standard involves intrapartum antibiotic prophylaxis (IAP). The Centers for Disease Control and Prevention (CDC) recommends intravenous penicillin G as the first-line agent, administered at least 4 hours before delivery. Alternatives for penicillin-allergic patients include cefazolin, clindamycin, or vancomycin, with specific recommendations depending on the allergy type and local resistance patterns. Beyond IAP, risk-based assessment strategies, including assessing gestational age, presence of fever, and rupture of membranes, contribute to informed clinical decisions and optimal patient care. Explore how integrating these factors can further refine your GBS management protocol and improve neonatal outcomes. Consider implementing a standardized protocol based on the latest CDC guidelines for consistent and effective GBS management.

Q: How do I interpret conflicting GBS test results during pregnancy (e.g., positive rectovaginal culture, negative urine culture) and determine appropriate intrapartum antibiotic prophylaxis?

A: Discrepancies in GBS test results during pregnancy can create clinical uncertainty regarding IAP. A positive rectovaginal culture, even with a negative urine culture, generally indicates GBS colonization and warrants IAP. This is because the rectovaginal culture is the gold standard screening test for GBS, directly assessing the presence of bacteria in the birth canal. While a urine culture can sometimes detect GBS, a negative result does not rule out colonization. Therefore, focus on the positive rectovaginal culture and proceed with IAP according to established guidelines. Learn more about the specific recommendations for antibiotic choices and administration timing to ensure optimal protection for the neonate. Consider implementing a clear algorithm for interpreting conflicting GBS test results in your practice to ensure consistent and appropriate management.

Quick Tips

Practical Coding Tips
  • Code O98.7- for GBS in pregnancy
  • Document GBS status clearly
  • Confirm GBS test timing
  • Z34.8- for screening
  • B95.1 if newborn affected

Documentation Templates

Group B Streptococcus (GBS) positive in pregnancy documented. Patient presents with a positive GBS recto-vaginal culture obtained at 35-37 weeks gestation as part of routine prenatal screening for Group B Strep colonization.  The patient reports no current signs or symptoms of infection such as fever, chills, urinary tract infection, or preterm labor.  Medical history is significant for (insert relevant medical history, e.g., gestational diabetes, previous GBS positive pregnancy, etc.).  Physical exam reveals no abnormal findings.  Diagnosis of GBS colonization in pregnancy confirmed. Plan includes intrapartum antibiotic prophylaxis (IAP) with intravenous penicillin G during labor as per CDC guidelines to prevent neonatal GBS infection.  Patient education provided regarding the risks and benefits of IAP, including potential allergic reactions.  Alternative intrapartum antibiotics discussed and documented if penicillin allergy exists.  Patient advised to report any signs or symptoms of infection immediately.  Follow-up at next scheduled prenatal appointment.  ICD-10 code O98.71, GBS colonization in pregnancy, applies.  Z3A.00, Encounter for supervision of normal pregnancy, is also appropriate.  This documentation supports medical billing and coding for GBS screening and management during pregnancy.